Panion reports successful safety study in dogs
Panion Animal Health AB develops a unique new gene therapy treatment for dogs with epilepsy. In spring 2018, a safety study in dogs was started under the lead of Associate Professor David Woldbye, Department of Neuroscience, University of Copenhagen. The clinical phase of the study is now finalised, and the first preliminary outcome can be reported. All treated dogs have successfully completed the study without observable adverse reactions. Neurological examination of the dogs before and after the treatment showed no related changes, and the dogs exhibited ordinary behavior shortly after